Eastman Chemical Company (NYSE: EMN) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 18.07 | EPS (ttm) | 3.87 | Insider Own | 1.22% | Shs Outstand | 114.35M | Perf Week | 2.57% |
| Market Cap | 8.00B | Forward P/E | 10.26 | EPS next Y | 6.82 | Insider Trans | -0.12% | Shs Float | 113.21M | Perf Month | 4.26% |
| Enterprise Value | 7.31B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 4.74% | Perf Quarter | -4.30% |
| Income | 442.33M | P/S | 0.90 | EPS this Y | 81.04% | Inst Trans | - | Short Ratio | 4.44 | Perf Half Y | 1.39% |
| Sales | 8.87B | P/B | 1.31 | EPS next Y | 8.88% | ROA | 2.87% | Short Interest | 5.36M | Perf YTD | 9.59% |
| Book/sh | - | P/C | 8.07 | EPS next 5Y | 9.62% | ROE | 7.42% | 52W High | 85.89 -16.20% | Perf Year | -4.74% |
| Cash/sh | - | P/FCF | 14.84 | EPS past 3/5Y | -13.57% 3.22% | ROIC | 5.46% | 52W Low | 57.74 24.67% | Perf 3Y | -20.53% |
| Dividend Est. | 3.36 (4.67%) | EV/EBITDA | 5.75 | Sales past 3/5Y | -5.99% 0.67% | Gross Margin | 19.88% | Volatility | 3.41% 2.83% | Perf 5Y | -36.44% |
| Dividend TTM | 3.35 (4.65%) | EV/Sales | 0.82 | EPS Y/Y TTM | -54.89% | Oper. Margin | 9.41% | ATR (14) | 2.15 | Perf 10Y | -2.87% |
| Dividend Ex-Date | Jun 15, 2026 | Quick Ratio | 0.76 | Sales Y/Y TTM | -7.92% | Profit Margin | 4.99% | RSI (14) | 53.77 | Recom | 2.46 |
| Dividend Gr. 3/5Y | 2.75% 4.52% | Current Ratio | 1.50 | EPS Q/Q | -42.93% | SMA20 | 2.42% | Beta | 1.08 | Target Price | 79.56 |
| Payout | 86.43% | Debt/Eq | 0.00 | Sales Q/Q | -4.93% | SMA50 | -1.15% | Rel Volume | 1.45 | Prev Close | 69.95 |
| Employees | 13,000 | LT Debt/Eq | 0.73 | Earnings | Nov 02 | SMA200 | 1.24% | Avg Volume | 1.24M | Price | 71.98 |
| IPO Date | Dec 14, 1993 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.48% 0.23% | Net Debt/EBITDA | -0.54 | Volume | 1,803,043 | Change | 2.90% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-16-26 | Reiterated | Goldman Sachs | Neutral | $83 → $75 |
| Jul-02-26 | Reiterated | Morgan Stanley | Overweight | $83 → $79 |
| May-05-26 | Reiterated | Deutsche Bank | Hold | $75 → $82 |
| May-05-26 | Reiterated | RBC Capital | Sector Perform | $79 → $82 |
| May-05-26 | Reiterated | Morgan Stanley | Overweight | $115 → $83 |
| May-04-26 | Reiterated | Wells Fargo | Equal Weight | $70 → $80 |
| May-01-26 | Reiterated | Mizuho Securities | Outperform | $80 → $85 |
| Apr-14-26 | Upgrade | JP Morgan | Neutral → Overweight | |
| Apr-09-26 | Reiterated | UBS | Buy | $75 → $88 |
| Feb-18-26 | Reiterated | Evercore ISI Group | In Line | $75 |
Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators. Additional offerings include specialty coalescents, various commodity and specialty solvents, paint additives, specialty polymers, heat transfer and aviation fluids, and rubber additives such as insoluble sulfur and anti-degradants, along with performance resins. These products cater to diverse sectors such as transportation, personal care, wellness, food, agriculture, construction, water treatment, energy, consumables, durables, and electronics. The Advanced Materials segment produces high-performance products including copolyesters, cellulosic biopolymers, cellulose esters, and polyvinyl butyral (PVB) sheets. It further supplies a variety of window and protective films, including those applied aftermarket, for high-value applications in transportation, consumer durables, electronics, building and construction, medical, pharmaceutical, and general consumables markets. Through its Chemical Intermediates segment, Eastman delivers essential chemical building blocks. This encompasses methylamines and their salts, various higher amines and solvents, olefin and acetyl derivatives, ethylene, and both primary phthalate and non-phthalate plasticizers, including specialized non-phthalate alternatives. These intermediates are vital for industrial chemical processes, construction, health and wellness products, and agrochemical formulations. Lastly, the Fibers segment is a significant producer of cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride, primarily for filtration media, notably cigarette filters. It also furnishes natural and solution-dyed acetate yarns for consumables and health and wellness markets, alongside wet-laid nonwoven media, specialty engineered papers, and cellulose acetate fibers for the transportation, industrial, agriculture, mining, and aerospace industries. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,865 | 8,752 | 9,382 | 9,198 | 10,535 | 10,483 | 8,464 | 9,247 | 10,122 | |
| Cost of Goods Sold Incl. D&A | 7,103 | 6,908 | 7,092 | 7,136 | 8,479 | 7,965 | 6,459 | 6,999 | 7,693 | |
| Gross Profit | 1,762 | 1,844 | 2,290 | 2,062 | 2,056 | 2,518 | 2,005 | 2,248 | 2,429 | |
| Selling, General and Administrative Excl. Other | 682 | 658 | 664 | 727 | 708 | 795 | 654 | 691 | 721 | |
| Research and Development | 246 | 255 | 250 | 239 | 264 | 254 | 226 | 234 | 235 | |
| Other Operating Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Income | 834 | 931 | 1,376 | 1,096 | 1,084 | 1,469 | 1,125 | 1,323 | 1,473 | |
| Interest Expense | 212 | 208 | 216 | 225 | 188 | 192 | 205 | 221 | 238 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -84 | -155 | -82 | 216 | 81 | -195 | -390 | -200 | 75 | |
| Net Income Before Taxes | 538 | 568 | 1,078 | 1,087 | 977 | 1,082 | 530 | 902 | 1,310 | |
| Income Taxes | 95 | 93 | 170 | 191 | 181 | 215 | 41 | 140 | 226 | |
| Consolidated Net Income | 442 | 474 | 905 | 894 | 793 | 857 | 478 | 759 | 1,080 | |
| Net Income From Continuing Operations | 443 | 475 | 908 | 896 | 796 | 867 | 489 | 762 | 1,084 | |
| Net Income | 442 | 474 | 905 | 894 | 793 | 857 | 478 | 759 | 1,080 | |
| EPS (Recurring) | 3.87 | 4.13 | 7.75 | 7.54 | 6.42 | 6.35 | 3.53 | 5.52 | 7.65 | |
| EPS (Basic, Before Extraordinaries) | 3.87 | 4.13 | 7.75 | 7.54 | 6.42 | 6.35 | 3.53 | 5.52 | 7.65 | |
| EPS (Diluted) | 3.85 | 4.10 | 7.67 | 7.49 | 6.35 | 6.25 | 3.50 | 5.48 | 7.56 | |
| EBITDA | 1,272 | 1,289 | 1,803 | 1,807 | 1,636 | 1,812 | 1,309 | 1,727 | 2,144 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.70 | 15.57 | 11.91 | 11.99 | 12.83 | 19.35 | 28.65 | 14.46 | 9.67 | |
| Price To Sales Ratio | 0.93 | 0.84 | 1.14 | 1.16 | 0.96 | 1.56 | 1.61 | 1.17 | 1.02 | |
| Gross Margin | 19.88 | 21.07 | 24.41 | 22.42 | 19.52 | 24.02 | 23.69 | 24.31 | 24.00 | |
| Operating Margin | 9.41 | 10.64 | 14.67 | 11.92 | 10.29 | 14.01 | 13.29 | 14.31 | 14.55 | |
| Net Margin | 4.99 | 5.42 | 9.65 | 9.72 | 7.53 | 8.18 | 5.65 | 8.21 | 10.67 | |
| Shares Outstanding | 114 | 115 | 117 | 119 | 124 | 135 | 136 | 137 | 141 | |
| Market Capitalization | 8,206 | 7,340 | 10,684 | 10,689 | 10,099 | 16,323 | 13,638 | 10,859 | 10,309 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Holt Adrian James | SVP, Chf HR Ofcr | May 05 '26 | Sale | 77.05 | 1,709 | 131,678 | 0 | May 07 |
| Costa Mark J | CEO & Board Chair | Feb 04 '26 | Option Exercise | 65.16 | 48,649 | 3,169,969 | 502,635 | Feb 06 |
| McLain William Thomas Jr. | EVP, CFO | Feb 04 '26 | Option Exercise | 65.16 | 3,013 | 196,327 | 56,537 | Feb 06 |
| Caveness Michelle H | SVP & Chf. Mfg. Ofc. | Oct 01 '25 | Option Exercise | 0.00 | 6,715 | 0 | 7,882 | Oct 02 |
| SMITH BRIAN TRAVIS | EVP, AFP, Mfg., WWEC & HSE | Aug 27 '25 | Buy | 68.34 | 1,750 | 119,595 | 16,732 | Aug 29 |
| BEGEMANN BRETT D | Director | Aug 27 '25 | Buy | 68.28 | 1,500 | 102,428 | 9,520 | Aug 28 |
| Audia Damon J | Director | Aug 27 '25 | Buy | 68.58 | 1,465 | 100,477 | 1,597 | Aug 28 |
| McAlindon Julie A. | SVP, Regions & Chf SupChn Ofcr | Aug 27 '25 | Buy | 68.43 | 2,000 | 136,859 | 12,731 | Aug 28 |
| McLain William Thomas Jr. | EVP, CFO | Aug 27 '25 | Buy | 68.73 | 3,670 | 252,239 | 53,524 | Aug 28 |
| Costa Mark J | CEO & Board Chair | Aug 27 '25 | Buy | 67.89 | 7,400 | 502,386 | 453,986 | Aug 28 |
| LICH BRAD A | EVP & CCO | Aug 27 '25 | Buy | 68.49 | 3,280 | 224,647 | 83,487 | Aug 28 |
| OBRIEN JAMES J /KY | Director | Aug 27 '25 | Buy | 68.81 | 1,450 | 99,776 | 6,828 | Aug 28 |
| Mink Kim Ann | Director | Aug 27 '25 | Buy | 69.38 | 1,450 | 100,601 | 2,840 | Aug 28 |
| Holder Julie Fasone | Director | Aug 27 '25 | Buy | 68.80 | 1,453 | 99,966 | 17,546 | Aug 28 |
| BUTLER ERIC L | Director | Aug 27 '25 | Buy | 68.65 | 3,000 | 205,958 | 9,330 | Aug 28 |